IL1RN Kit CLIA
-
- Antigène Voir toutes IL1RN Kits CLIA
- IL1RN (Interleukin 1 Receptor Antagonist (IL1RN))
-
Reactivité
- Souris
- Méthode de détection
- Chemiluminescent
- Type de méthode
- Sandwich ELISA
- Gamme de detection
- 3.12 pg/mL - 200 pg/mL
- Seuil minimal de détection
- 3.12 pg/mL
- Application
- ELISA
- Fonction
- Mouse Interleukin 1 Receptor Antagonist (IL1RA) CLIA Kit is a Sandwich CLIA Kit for use with Serum, plasma, tissue homogenates and other biological fluids.
- Type d'échantillon
- Plasma, Serum, Tissue Homogenate
- Analytical Method
- Quantitative
- Sensibilité
- < 1.33 pg/mL
- Featured
- Discover our best selling IL1RN Kit ELISA
- Top Product
- Discover our top product IL1RN Kit ELISA
-
-
- Indications d'application
-
Stability: The stability of the kit is determined by the rate of activity loss. The loss rate is less than 5 % within the expiration date under appropriate storage conditions. To minimize performance fluctuations, operation procedures and lab conditions should be strictly controlled. It is also strongly suggested that the whole assay is performed by the same user throughout.
Recommended dilutions: Optimal dilutions/concentrations should be determined by the end user.
Standard Form: Lyophilized
- Plaque
- Pre-coated
- Restrictions
- For Research Use only
-
- Stock
- 4 °C/-20 °C
- Stockage commentaire
- Upon receipt, store the kit according to the storage instruction in the kit's manual.
- Date de péremption
- 6 months
-
- Antigène Voir toutes IL1RN Kits CLIA
- IL1RN (Interleukin 1 Receptor Antagonist (IL1RN))
- Autre désignation
- IL1RA (IL1RN Produits)
- Synonymes
- DIRA Kit CLIA, ICIL-1RA Kit CLIA, IL-1RN Kit CLIA, IL-1ra Kit CLIA, IL-1ra3 Kit CLIA, IL1F3 Kit CLIA, IL1RA Kit CLIA, IRAP Kit CLIA, MVCD4 Kit CLIA, IRAP1 Kit CLIA, IL1RN Kit CLIA, IL-1RA Kit CLIA, F630041P17Rik Kit CLIA, interleukin 1 receptor antagonist Kit CLIA, interleukin 1 receptor antagonist-like Kit CLIA, IL1RN Kit CLIA, Il1rn Kit CLIA, IL1RNL Kit CLIA
- Pathways
- Signalisation NF-kappaB, Hormone Transport, Cancer Immune Checkpoints
-